mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.006 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |